ID

24684

Descripción

Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers; ODM derived from: https://clinicaltrials.gov/show/NCT00488592

Link

https://clinicaltrials.gov/show/NCT00488592

Palabras clave

Versiones (1)
  1. 13/8/17 13/8/17 -
Subido en

13 de agosto de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Myelodysplastic Syndrome (MDS) NCT00488592

Inglés

Eligibility Myelodysplastic Syndrome (MDS) NCT00488592

1 formularios  
Criteria
Descripción

Criteria

diagnosed with mds (b subtypes refractory anemia (ra), refractory anemia with ring sideroblasts (rars) -low risk) (mds with 5q- must have failed lenalidomide or been ineligible to receive it)
Descripción

MYELODYSPLASTIC SYNDROME | Subtype Refractory anemia | Subtype Refractory anemia with ringed sideroblasts Low Risk | 5q minus syndrome | Lenalidomide failed | Patient Ineligible Lenalidomide

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3463824
UMLS CUI [2,1]
C0449560
UMLS CUI [2,2]
C0002893
UMLS CUI [3,1]
C0449560
UMLS CUI [3,2]
C1264195
UMLS CUI [3,3]
C3538919
UMLS CUI [4]
C1292779
UMLS CUI [5,1]
C1144149
UMLS CUI [5,2]
C0231175
UMLS CUI [6,1]
C0030705
UMLS CUI [6,2]
C1512714
UMLS CUI [6,3]
C1144149
diagnosed with aml and in complete remission within 5 years of treatment with less than 5% marrow blasts
Descripción

Acute myeloid leukemia in remission | Blasts Bone marrow Percentage

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0153886
UMLS CUI [2,1]
C1982687
UMLS CUI [2,2]
C0439165
diagnosed with cml in chronic phase
Descripción

Leukemia, Myeloid, Chronic-Phase

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023474
unsuitable for stem cell transplantation (sct) (age over sixty or unavailability of a fully-matched donor)
Descripción

Patient Inappropriate Stem cell transplantation | Age Relationship | Tissue Donor HLA Matched Unavailable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1548788
UMLS CUI [1,3]
C1504389
UMLS CUI [2,1]
C0001779
UMLS CUI [2,2]
C0439849
UMLS CUI [3,1]
C0040288
UMLS CUI [3,2]
C1548978
UMLS CUI [3,3]
C0686905
made an informed decision not to undergo the transplant procedure
Descripción

Transplantation Refused

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0040732
UMLS CUI [1,2]
C1705116
are between 6 months 3 years following allogeneic sct and fulfill the following criteria:
Descripción

Allogeneic Stem Cell Transplantation Status post | Criteria Fulfill

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2242529
UMLS CUI [1,2]
C0231290
UMLS CUI [2,1]
C0243161
UMLS CUI [2,2]
C1550543
100% donor engraftment,
Descripción

Tissue Donor Graft acceptance Percentage

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0040288
UMLS CUI [1,2]
C0301944
UMLS CUI [1,3]
C0439165
less than 5% blasts in marrow
Descripción

Blasts Bone marrow Percentage

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1982687
UMLS CUI [1,2]
C0439165
normal marrow cellularity
Descripción

Bone marrow cellularity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1561532
human leukocyte antigen (hla-a020 1) positive at one allele
Descripción

HLA-A0201 Positive Allele Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1097566
UMLS CUI [1,2]
C1514241
UMLS CUI [1,3]
C0002085
UMLS CUI [1,4]
C1265611
ages 18-85 years old
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
off all lympho-ablative chemotherapeutic agents
Descripción

Lymph node Ablation | Antineoplastic Agents Discontinued

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0024204
UMLS CUI [1,2]
C0547070
UMLS CUI [2,1]
C0003392
UMLS CUI [2,2]
C1444662
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
hypoplastic mds
Descripción

MYELODYSPLASTIC SYNDROME Hypoplastic

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3463824
UMLS CUI [1,2]
C0543481
relapsed aml
Descripción

Recurrent adult acute myeloid leukemia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0278780
cml in accelerated phase or blast crisis
Descripción

Leukemia, Myeloid, Accelerated Phase | Chronic myelogenous leukemia with crisis of blast cells

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023472
UMLS CUI [2]
C2861579
hypocellular bone marrow (less than 20%)
Descripción

Bone marrow depression Percentage

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0151773
UMLS CUI [1,2]
C0439165
history of wegener's granulomatosis
Descripción

Granulomatosis with polyangiitis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3495801
serologic antibody against proteinase-3 (anca positive)
Descripción

Proteinase-3 antibody Serologic | ANCA positive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0443910
UMLS CUI [1,2]
C0205473
UMLS CUI [2]
C0238874
previous allergic reaction to montanide adjuvant
Descripción

Allergic Reaction Montanide ISA 51 Adjuvant

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1527304
UMLS CUI [1,2]
C1311732
UMLS CUI [1,3]
C0001552
positive test for hiv
Descripción

HIV Seropositivity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019699
treatment with systemic corticosteroids or immunosuppressants within 14 days prior to study entry
Descripción

CORTICOSTEROIDS FOR SYSTEMIC USE | Immunosuppressive Agents Systemic

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3653708
UMLS CUI [2,1]
C0021081
UMLS CUI [2,2]
C0205373
co-morbidity of such severity that it would preclude the patient's ability to tolerate protocol therapy
Descripción

Comorbidity Severe | Investigational Therapy Receive Unable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0949266
UMLS CUI [2,2]
C1514756
UMLS CUI [2,3]
C1299582
predicted survival less than 28 days
Descripción

Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
pregnant or breast feeding (all female patients must have a urine pregnancy test within 1 week prior to vaccine administration)
Descripción

Pregnancy | Breast Feeding | Gender Urine pregnancy test | Administration of vaccine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C0079399
UMLS CUI [3,2]
C0430056
UMLS CUI [4]
C2368628
unwilling to practice abstinence or effective contraception (men and women) during the study period.
Descripción

Sexual Abstinence Unwilling | Contraceptive methods Unwilling

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0036899
UMLS CUI [1,2]
C0558080
UMLS CUI [2,1]
C0700589
UMLS CUI [2,2]
C0558080
enrolled in another drug or vaccine clinical trial during the study period
Descripción

Study Subject Participation Status | Investigational New Drugs | Vaccines

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
UMLS CUI [3]
C0042210
inability to comprehend the investigational nature of the study and provide informed consent
Descripción

Study Protocol Comprehension Unable | Informed Consent Unable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2348563
UMLS CUI [1,2]
C0162340
UMLS CUI [1,3]
C1299582
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C1299582
Volver a la parte superior de la página

Similar models

Eligibility Myelodysplastic Syndrome (MDS) NCT00488592

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
MYELODYSPLASTIC SYNDROME | Subtype Refractory anemia | Subtype Refractory anemia with ringed sideroblasts Low Risk | 5q minus syndrome | Lenalidomide failed | Patient Ineligible Lenalidomide
Item
diagnosed with mds (b subtypes refractory anemia (ra), refractory anemia with ring sideroblasts (rars) -low risk) (mds with 5q- must have failed lenalidomide or been ineligible to receive it)
boolean
C3463824 (UMLS CUI [1])
C0449560 (UMLS CUI [2,1])
C0002893 (UMLS CUI [2,2])
C0449560 (UMLS CUI [3,1])
C1264195 (UMLS CUI [3,2])
C3538919 (UMLS CUI [3,3])
C1292779 (UMLS CUI [4])
C1144149 (UMLS CUI [5,1])
C0231175 (UMLS CUI [5,2])
C0030705 (UMLS CUI [6,1])
C1512714 (UMLS CUI [6,2])
C1144149 (UMLS CUI [6,3])
Acute myeloid leukemia in remission | Blasts Bone marrow Percentage
Item
diagnosed with aml and in complete remission within 5 years of treatment with less than 5% marrow blasts
boolean
C0153886 (UMLS CUI [1])
C1982687 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
Leukemia, Myeloid, Chronic-Phase
Item
diagnosed with cml in chronic phase
boolean
C0023474 (UMLS CUI [1])
Patient Inappropriate Stem cell transplantation | Age Relationship | Tissue Donor HLA Matched Unavailable
Item
unsuitable for stem cell transplantation (sct) (age over sixty or unavailability of a fully-matched donor)
boolean
C0030705 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
C1504389 (UMLS CUI [1,3])
C0001779 (UMLS CUI [2,1])
C0439849 (UMLS CUI [2,2])
C0040288 (UMLS CUI [3,1])
C1548978 (UMLS CUI [3,2])
C0686905 (UMLS CUI [3,3])
Transplantation Refused
Item
made an informed decision not to undergo the transplant procedure
boolean
C0040732 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])
Allogeneic Stem Cell Transplantation Status post | Criteria Fulfill
Item
are between 6 months 3 years following allogeneic sct and fulfill the following criteria:
boolean
C2242529 (UMLS CUI [1,1])
C0231290 (UMLS CUI [1,2])
C0243161 (UMLS CUI [2,1])
C1550543 (UMLS CUI [2,2])
Tissue Donor Graft acceptance Percentage
Item
100% donor engraftment,
boolean
C0040288 (UMLS CUI [1,1])
C0301944 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
Blasts Bone marrow Percentage
Item
less than 5% blasts in marrow
boolean
C1982687 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
Bone marrow cellularity
Item
normal marrow cellularity
boolean
C1561532 (UMLS CUI [1])
HLA-A0201 Positive Allele Quantity
Item
human leukocyte antigen (hla-a020 1) positive at one allele
boolean
C1097566 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
C0002085 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
Age
Item
ages 18-85 years old
boolean
C0001779 (UMLS CUI [1])
Lymph node Ablation | Antineoplastic Agents Discontinued
Item
off all lympho-ablative chemotherapeutic agents
boolean
C0024204 (UMLS CUI [1,1])
C0547070 (UMLS CUI [1,2])
C0003392 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
MYELODYSPLASTIC SYNDROME Hypoplastic
Item
hypoplastic mds
boolean
C3463824 (UMLS CUI [1,1])
C0543481 (UMLS CUI [1,2])
Recurrent adult acute myeloid leukemia
Item
relapsed aml
boolean
C0278780 (UMLS CUI [1])
Leukemia, Myeloid, Accelerated Phase | Chronic myelogenous leukemia with crisis of blast cells
Item
cml in accelerated phase or blast crisis
boolean
C0023472 (UMLS CUI [1])
C2861579 (UMLS CUI [2])
Bone marrow depression Percentage
Item
hypocellular bone marrow (less than 20%)
boolean
C0151773 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
Granulomatosis with polyangiitis
Item
history of wegener's granulomatosis
boolean
C3495801 (UMLS CUI [1])
Proteinase-3 antibody Serologic | ANCA positive
Item
serologic antibody against proteinase-3 (anca positive)
boolean
C0443910 (UMLS CUI [1,1])
C0205473 (UMLS CUI [1,2])
C0238874 (UMLS CUI [2])
Allergic Reaction Montanide ISA 51 Adjuvant
Item
previous allergic reaction to montanide adjuvant
boolean
C1527304 (UMLS CUI [1,1])
C1311732 (UMLS CUI [1,2])
C0001552 (UMLS CUI [1,3])
HIV Seropositivity
Item
positive test for hiv
boolean
C0019699 (UMLS CUI [1])
CORTICOSTEROIDS FOR SYSTEMIC USE | Immunosuppressive Agents Systemic
Item
treatment with systemic corticosteroids or immunosuppressants within 14 days prior to study entry
boolean
C3653708 (UMLS CUI [1])
C0021081 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
Comorbidity Severe | Investigational Therapy Receive Unable
Item
co-morbidity of such severity that it would preclude the patient's ability to tolerate protocol therapy
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0949266 (UMLS CUI [2,1])
C1514756 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
Life Expectancy
Item
predicted survival less than 28 days
boolean
C0023671 (UMLS CUI [1])
Pregnancy | Breast Feeding | Gender Urine pregnancy test | Administration of vaccine
Item
pregnant or breast feeding (all female patients must have a urine pregnancy test within 1 week prior to vaccine administration)
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0079399 (UMLS CUI [3,1])
C0430056 (UMLS CUI [3,2])
C2368628 (UMLS CUI [4])
Sexual Abstinence Unwilling | Contraceptive methods Unwilling
Item
unwilling to practice abstinence or effective contraception (men and women) during the study period.
boolean
C0036899 (UMLS CUI [1,1])
C0558080 (UMLS CUI [1,2])
C0700589 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
Study Subject Participation Status | Investigational New Drugs | Vaccines
Item
enrolled in another drug or vaccine clinical trial during the study period
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C0042210 (UMLS CUI [3])
Study Protocol Comprehension Unable | Informed Consent Unable
Item
inability to comprehend the investigational nature of the study and provide informed consent
boolean
C2348563 (UMLS CUI [1,1])
C0162340 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0021430 (UMLS CUI [2,1])
C1299582 (UMLS CUI [2,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial